{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:14:28Z","timestamp":1779167668212,"version":"3.51.4"},"reference-count":25,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Despite an established treatment algorithm for overactive bladder (OAB), it is unclear how many patients proceed through each step. Our objective was to evaluate the percentage of patients receiving each step of care and identify reasons why patients did not receive certain treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a retrospective cohort study with cross-sectional survey of new OAB patients. The medical record was queried for relevant patient characteristics and documentation of conservative, medical, and third-line therapies. In the survey, patients were asked about current bladder symptoms and reasons why they did not use certain treatments. Descriptive statistics were used for analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      One hundred eleven patients met the inclusion criteria; the most common diagnosis was mixed incontinence (40%,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200945). The median number of visits for OAB was 2 (range 1\u20138). On retrospective analysis, 64% (71) of patients had documented attempts at conservative therapy. Seventy-six percent (84) of patients attempted medical therapy, and only 11% (12) progressed to any third-line therapy. Fifty-nine percent (64) of eligible patients responded to the survey. Fifty-three percent (34) of respondents reported persistent moderate to very severe bother due to bladder symptoms. Thirty percent to fifty percent of patients who did not attempt one or more of the three levels of OAB therapy reported that they were never offered that treatment option.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Many patients do not progress to the next steps in OAB therapy despite failure of more conservative treatments. Barriers to care included limited follow-up and education about other therapy options. A formalized institutional care pathway may lead to improved OAB treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jwh.2021.0635","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T10:11:08Z","timestamp":1648807868000},"page":"1314-1319","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Why Patients Fall Through the Cracks: Assessment of Patients' Overactive Bladder Treatment"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2842-748X","authenticated-orcid":false,"given":"Emily R.W.","family":"Davidson","sequence":"first","affiliation":[{"name":"Center for Urogynecology and Pelvic Reconstructive Surgery, Obstetrics, Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"Miceli","sequence":"additional","affiliation":[{"name":"Center for Urogynecology and Pelvic Reconstructive Surgery, Obstetrics, Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Propst","sequence":"additional","affiliation":[{"name":"Center for Urogynecology and Pelvic Reconstructive Surgery, Obstetrics, Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09993.x"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-002-0301-4"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.23277"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2014.11.019"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.09.079"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.01.087"},{"key":"e_1_3_4_8_2","first-page":"1047","article-title":"Persistence and adherence with urinary antispasmodic medications among employees and the impact of adherence on costs and absenteeism","volume":"20","author":"Kleinman NL","year":"2014","unstructured":"Kleinman NL, , Odell K, , Chen CI, , Atkinson A, , Zou KH. Persistence and adherence with urinary antispasmodic medications among employees and the impact of adherence on costs and absenteeism. J Manag Care Spec Pharm, 2014; 20:1047\u20131056.","journal-title":"J Manag Care Spec Pharm"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.09036.x"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00617.x"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.06.047"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004279"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.09.102"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003320"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.JU.0000556187.31898.92"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.01.007"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","unstructured":"JMP\u00ae. Version 14. 1989\u20132007.","DOI":"10.1016\/S0262-1762(07)70353-X"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000488932"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/JHQ.0000000000000247"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.108769"},{"key":"e_1_3_4_22_2","first-page":"113","article-title":"Evaluation and management of overactive bladder: Strategies for optimizing care","volume":"8","author":"Willis-Gray MG","year":"2016","unstructured":"Willis-Gray MG, , Dieter AA, , Geller EJ. Evaluation and management of overactive bladder: Strategies for optimizing care. Res Rep Urol, 2016; 8:113\u2013122.","journal-title":"Res Rep Urol"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003422"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-021-04686-1"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2014.11.017"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmrj.2017.11.008"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2021.0635","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2021.0635","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2021.0635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:56:41Z","timestamp":1777658201000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jwh.2021.0635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1089\/jwh.2021.0635"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2021.0635","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}